Tag: postmarket surveillance

How the FDA Monitors Drug Safety After Medication Approval

By Joe Barnett    On 2 Feb, 2026    Comments (10)

blog-post-image

The FDA doesn't stop monitoring drugs after approval. Using FAERS, Sentinel, AI tools, and REMS programs, it tracks side effects in millions of real-world patients to catch hidden risks and protect public health.

View More

Categories

Recent Post

recent-post-image Genetic Testing for Cancer Risk: BRCA, Lynch, and Beyond
recent-post-image Alcohol Types and Medication Safety: Risks of Spirits, Wine, and Beer
recent-post-image Pharmacist Responsibilities When Dispensing Generics: Legal Obligations in the U.S.
recent-post-image Tendering Systems: Europe's Approach to Generic Purchasing Explained
recent-post-image Post-market studies on generic drug safety: clinical follow-up

Menu

© 2026. All rights reserved.